Long-Term Follow-up Study of FURESTEM-AD in Patients With Atopic Dermatitis(K0106)

Long-Term Follow-up Study of Subjects With Moderate to Severe Chronic Atopic Dermatitis Who Had Administered FURESTEM-AD Inj. in K0106 Study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07582237

Enrollment

262

Registered

2026-05-12

Start date

2021-10-05

Completion date

2029-02-21

Last updated

2026-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dermatitis, Atopic

Keywords

Atopic Dermatitis, AD, Stem Cell, Furestem

Brief summary

Long-Term Follow-up Study of Subjects With Moderate to Severe Chronic Atopic Dermatitis Who Had Administered FURESTEM-AD Inj. in K0106 Study

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

19 Years to No maximum

Healthy volunteers

Inclusion criteria

* Those who participated in the K0106 clinical trial and received FURESTEM-AD Inj * Those who understand and voluntarily sign an informed consent form

Exclusion criteria

* None

Design outcomes

Primary

Measure	Time frame	Description
Safety Assessment	5 years follow-up after treatment	Rate and Number of AESI(Adverse Event of Special Interest) and SS(Special Situation)

Secondary

Measure	Time frame
EASI(Eczema Area and Severity Index) Score	1 year, 2 years, 3 years after treatment
IGA(Investigator's Global Assessment) Score	1 year, 2 years, 3 years after treatment
Pruritus NRS(Numerical Rating Scale) Score	1 year, 2 years, 3 years after treatment

Countries

South Korea

Contacts

PRINCIPAL_INVESTIGATORYeonglib Park, professor (CI)

Bucheon Hospital, Soonchunhyang University

PRINCIPAL_INVESTIGATORYangwon Lee, professor

Konkuk University Hospital

PRINCIPAL_INVESTIGATORSanguk Son, professor

Korea University Ansan Hospital

PRINCIPAL_INVESTIGATORBakrin Yoo, professor

Gangdong Kyunghee University Hospital

PRINCIPAL_INVESTIGATORJihyun Lee, professor

Seoul St. Mary's Hospital

PRINCIPAL_INVESTIGATORDonghoon Lee, professor

Seoul National University Hospital

PRINCIPAL_INVESTIGATORChanho Na, professor

Chosun University Hospital

PRINCIPAL_INVESTIGATORYooin Bae, professor

Hallym University Dongtan Seongsim Hospital

PRINCIPAL_INVESTIGATORHyunchang Ko, professor

Yangsan Pusan National University Hospital

PRINCIPAL_INVESTIGATORYounghyun Jang, professor

Kyungpook National University Hospital

PRINCIPAL_INVESTIGATORHoon Kang, professor

The Catholic University of Korea Eunpyeong St. Mary's Hospital

PRINCIPAL_INVESTIGATORMinkyung Shin, professor

Kyunghee University Hospital

PRINCIPAL_INVESTIGATORSanghyun Cho, professor

Catholic University Incheon St. Mary's Hospital

PRINCIPAL_INVESTIGATORCheonuk Park, professor

Hallym University Kangnam Sacred Heart Hospital

PRINCIPAL_INVESTIGATORJooyeon Ko, professor

Hanyang University

PRINCIPAL_INVESTIGATORTaeyoung Han, professor

Nowon Eulji University Hospital

PRINCIPAL_INVESTIGATORJiyoung Ahn, professor

National medical center

PRINCIPAL_INVESTIGATORYuchan Kim, professor

Ajou University School of Medicine

PRINCIPAL_INVESTIGATORSungyeol Lee, professor

Soon Chun Hyang University

PRINCIPAL_INVESTIGATORJunhong Min, professor

KangWon National University Hospital

Outcome results